Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruoxuan Xiang

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pharmaceutical Statistics|October 27, 2025
A Generalized Bayesian Hierarchical Model in Basket TrialsRuoxuan Xiang, John Scott
Immunological Investigations|January 11, 2024
Advances in Metabolic Regulation of Macrophage Polarization StateXin Liu, Ruoxuan Xiang, Xue Fang, et al.
International Immunopharmacology|August 24, 2022
Xanthones from Securidaca inappendiculata Hassk. attenuate collagen-induced arthritis in rats by inhibiting the nicotinamide phosphoribosyltransferase/glycolysis pathway and macrophage polarizationYuyan Zhou, Ruoxuan Xiang, Guozheng Qin, et al.
Immunologic Research|September 30, 2024
Anti-inflammatory effects of 1,7-dihydroxy-3,4-dimethoxyxanthone through inhibition of M1-phenotype macrophages via arginine/mitochondrial axisXin Liu, Ting Wang, Ruoxuan Xiang, et al.
Chemistry & Biodiversity|July 25, 2025
Optimization of Polyphenol Extraction From Securidaca inappendiculata Hassk. Using Response Surface Methodology and Evaluation of Its Antioxidant PotentialTing Wang, Yan Wang, Ruoxuan Xiang, et al.
International Immunopharmacology|December 8, 2022
Arctigenin mitigates insulin resistance by modulating the IRS2/GLUT4 pathway via TLR4 in type 2 diabetes mellitus miceYuyan Zhou, Lina Liu, Ruoxuan Xiang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2020
Reduced Influenza B-Specific Postvaccination Antibody Cross-reactivity in the B/Victoria Lineage-Predominant 2019/20 SeasonHang Xie, Ruoxuan Xiang, Hamilton J Wan, et al.
Nature Communications|November 13, 2021
SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strainsPeter Radvak, Hyung-Joon Kwon, Martina Kosikova, et al.
Iscience|November 14, 2022
Enhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 delta and beyondHyung-Joon Kwon, Martina Kosikova, Weichun Tang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pharmaceutical Statistics|October 27, 2025
A Generalized Bayesian Hierarchical Model in Basket TrialsRuoxuan Xiang, John Scott
Immunological Investigations|January 11, 2024
Advances in Metabolic Regulation of Macrophage Polarization StateXin Liu, Ruoxuan Xiang, Xue Fang, et al.
International Immunopharmacology|August 24, 2022
Xanthones from Securidaca inappendiculata Hassk. attenuate collagen-induced arthritis in rats by inhibiting the nicotinamide phosphoribosyltransferase/glycolysis pathway and macrophage polarizationYuyan Zhou, Ruoxuan Xiang, Guozheng Qin, et al.
Immunologic Research|September 30, 2024
Anti-inflammatory effects of 1,7-dihydroxy-3,4-dimethoxyxanthone through inhibition of M1-phenotype macrophages via arginine/mitochondrial axisXin Liu, Ting Wang, Ruoxuan Xiang, et al.
Chemistry & Biodiversity|July 25, 2025
Optimization of Polyphenol Extraction From Securidaca inappendiculata Hassk. Using Response Surface Methodology and Evaluation of Its Antioxidant PotentialTing Wang, Yan Wang, Ruoxuan Xiang, et al.
International Immunopharmacology|December 8, 2022
Arctigenin mitigates insulin resistance by modulating the IRS2/GLUT4 pathway via TLR4 in type 2 diabetes mellitus miceYuyan Zhou, Lina Liu, Ruoxuan Xiang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2020
Reduced Influenza B-Specific Postvaccination Antibody Cross-reactivity in the B/Victoria Lineage-Predominant 2019/20 SeasonHang Xie, Ruoxuan Xiang, Hamilton J Wan, et al.
Nature Communications|November 13, 2021
SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strainsPeter Radvak, Hyung-Joon Kwon, Martina Kosikova, et al.
Iscience|November 14, 2022
Enhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 delta and beyondHyung-Joon Kwon, Martina Kosikova, Weichun Tang, et al.
Pageof 1